{
  "age": 51,
  "gender": {
    "category": "Female",
    "intersex_condition": null
  },
  "weight": {
    "weight_kg": 63,
    "height_cm": 165,
    "bmi_category": "Healthy"
  },
  "ethnicity": "South Asian",
  "disease": {
    "name": "Lung Cancer",
    "diagnosed_years_ago": 1.2,
    "prognosis": "Stable"
  },
  "comorbidities": [],
  "treatments": [
    {
      "treatment_name": "Alectinib (Oral)",
      "dosage_mg_per_day": 450,
      "percent_week_administered": 200,
      "indication": "Primary"
    }
  ],
  "genetic_variants": [
    {
      "gene": "ALK",
      "variant": "EML4-ALK fusion",
      "effect": "Oncogenic fusion â€” predicts response to ALK inhibitors (e.g., alectinib)"
    }
  ]
}

